Hypertension Diagnostics, Inc.
HDII
$0.00
$0.000.00%
| 03/31/2013 | 12/31/2012 | ||||
|---|---|---|---|---|---|
| Revenue | -94.03% | -61.27% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -94.03% | -61.27% | |||
| Cost of Revenue | -28.57% | 76.80% | |||
| Gross Profit | 24.99% | -119.64% | |||
| SG&A Expenses | 62.52% | -42.39% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.35% | 7.78% | |||
| Operating Income | -3.11% | -15.42% | |||
| Income Before Tax | -8.30% | 1.29% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -8.30% | 1.29% | |||
| Earnings from Discontinued Operations | -137.45% | 241.79% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1,379.06% | 94.18% | |||
| EBIT | -3.11% | -15.42% | |||
| EBITDA | -1.05% | -16.80% | |||
| EPS Basic | -1,400.00% | 94.24% | |||
| Normalized Basic EPS | -7.55% | -20.45% | |||
| EPS Diluted | -290.91% | 78.57% | |||
| Normalized Diluted EPS | -23.91% | -4.55% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | -12.28% | 14.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
